301 related articles for article (PubMed ID: 31904179)
1. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
Sun H; Guo F; Xu L
J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
[TBL] [Abstract][Full Text] [Related]
2. MiR-301a-3p Advances IRAK1-Mediated Differentiation of Th17 Cells to Promote the Progression of Systemic Lupus Erythematosus via Targeting PELI1.
Luo S; Wu R; Li Q; Zhang G
J Healthc Eng; 2021; 2021():2982924. PubMed ID: 34931135
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of microRNA-448 suppresses CD4
Zhang J; Guo Y; Sun Y; Chang L; Wang X
Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
[TBL] [Abstract][Full Text] [Related]
4. Disabled-2 overexpression mediates immune suppression in systemic lupus erythematosus by modulating Treg/Th17 cell differentiation.
Zhang J; Chang L; Sun Y; Qin M; Wang X; Guo Y
Clin Exp Pharmacol Physiol; 2022 May; 49(5):596-607. PubMed ID: 35108421
[TBL] [Abstract][Full Text] [Related]
5. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
Ding S; Liang Y; Zhao M; Liang G; Long H; Zhao S; Wang Y; Yin H; Zhang P; Zhang Q; Lu Q
Arthritis Rheum; 2012 Sep; 64(9):2953-63. PubMed ID: 22549634
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
[TBL] [Abstract][Full Text] [Related]
8. miR-98 Modulates Cytokine Production from Human PBMCs in Systemic Lupus Erythematosus by Targeting IL-6 mRNA.
Yuan S; Tang C; Chen D; Li F; Huang M; Ye J; He Z; Li W; Chen Y; Lin X; Wang X; Cai X
J Immunol Res; 2019; 2019():9827574. PubMed ID: 31886314
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus.
Tao B; Xiang W; Li X; He C; Chen L; Xia X; Peng T; Peng L; Yang X; Zhong C
Inflamm Res; 2021 Mar; 70(3):285-296. PubMed ID: 33507312
[TBL] [Abstract][Full Text] [Related]
10. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
[TBL] [Abstract][Full Text] [Related]
11. CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus.
Wang X; Zhang C; Wu Z; Chen Y; Shi W
Arthritis Res Ther; 2018 Jun; 20(1):118. PubMed ID: 29884225
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of circETS1 disrupts Th17/Treg homeostasis by inhibiting
Ma S; Feng G; Li L; Li Z; Zhou X; Zhou Y; Zhang R
Lupus; 2023 Oct; 32(12):1430-1439. PubMed ID: 37852297
[TBL] [Abstract][Full Text] [Related]
13. Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.
Cheng T; Ding S; Liu S; Li X; Tang X; Sun L
Front Immunol; 2021; 12():668760. PubMed ID: 34093566
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
15. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.
Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z
J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
Tang Y; Luo X; Cui H; Ni X; Yuan M; Guo Y; Huang X; Zhou H; de Vries N; Tak PP; Chen S; Shen N
Arthritis Rheum; 2009 Apr; 60(4):1065-75. PubMed ID: 19333922
[TBL] [Abstract][Full Text] [Related]
17. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
18. NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker.
Guo G; Wang H; Shi X; Ye L; Wu K; Lin K; Ye S; Li B; Zhang H; Lin Q; Ye S; Xue X; Chen C
J Transl Med; 2018 Dec; 16(1):370. PubMed ID: 30577810
[TBL] [Abstract][Full Text] [Related]
19. Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus.
Xu L; Wang L; Shi Y; Deng Y; Oates JC; Kamen DL; Gilkeson GS; Wang F; Zhang M; Tan W; Tsao BP
Arthritis Rheumatol; 2022 Mar; 74(3):496-507. PubMed ID: 34569195
[TBL] [Abstract][Full Text] [Related]
20. Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients.
Lashine YA; Salah S; Aboelenein HR; Abdelaziz AI
Lupus; 2015 Mar; 24(3):240-7. PubMed ID: 25253569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
